IO Biotech presented posters on preclinical studies at SITC Annual Meeting

Nov 13, 2017

Copenhagen, Denmark – November 13, 2017: IO Biotech announced that two posters summarizing recent preclinical findings in the company’s leading products, IO102 and IO103, were exhibited over the weekend at the Society for Immunotherapy of Cancer (SITC) Annual Meeting, held in National Harbor, Maryland.

Other news

IO Biotech Announces Appointment of Devin Smith as General Counsel

IO Biotech Announces Appointment of Devin Smith as General Counsel

IO Biotech Provides Business Update

IO Biotech Provides Business Update